104 related articles for article (PubMed ID: 12879604)
21. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
23. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis.
Isidoro A; Casado E; Redondo A; Acebo P; Espinosa E; Alonso AM; Cejas P; Hardisson D; Fresno Vara JA; Belda-Iniesta C; González-Barón M; Cuezva JM
Carcinogenesis; 2005 Dec; 26(12):2095-104. PubMed ID: 16033770
[TBL] [Abstract][Full Text] [Related]
24. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
25. [Her-2/neu, Ki-67 expression and ploidy in breast carcinoma].
Lukashina MI; Glukhova EI; Zhukova LG; Ermilova VD; Bogatyrev VN; Baryshnikov AIu
Arkh Patol; 2003; 65(5):25-9. PubMed ID: 14664144
[TBL] [Abstract][Full Text] [Related]
26. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
27. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
29. Primary tumor location impacts breast cancer survival.
Sohn VY; Arthurs ZM; Sebesta JA; Brown TA
Am J Surg; 2008 May; 195(5):641-4. PubMed ID: 18424280
[TBL] [Abstract][Full Text] [Related]
30. [The role of the "communication systems" in individual prognosis of breast cancer].
Golubev OA
Arkh Patol; 2004; 66(1):22-8. PubMed ID: 15055105
[TBL] [Abstract][Full Text] [Related]
31. Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
Mylona EE; Alexandrou PT; Giannopoulou IA; Rafailidis PI; Markaki S; Keramopoulos A; Nakopoulou LL
Cancer Detect Prev; 2006; 30(2):111-7. PubMed ID: 16632244
[TBL] [Abstract][Full Text] [Related]
32. Apoptotic index: use in predicting recurrence in breast cancer patients.
Srinivas P; Abraham E; Ahamed I; Madhavan M; Vijayalakshmi NR; Nair MK; Balaram P
J Exp Clin Cancer Res; 2002 Jun; 21(2):233-8. PubMed ID: 12148584
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of early-stage synchronous bilateral invasive breast cancer.
Schmid SM; Pfefferkorn C; Myrick ME; Viehl CT; Obermann E; Schötzau A; Güth U
Eur J Surg Oncol; 2011 Jul; 37(7):623-8. PubMed ID: 21628090
[TBL] [Abstract][Full Text] [Related]
34. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
Fondrinier E; Guérin O; Lorimier G
Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
[TBL] [Abstract][Full Text] [Related]
35. Topoisomerase II alpha expression correlates with diminished disease-free survival in invasive breast cancer.
O'Connor JK; Hazard LJ; Avent JM; Lee RJ; Fischbach J; Gaffney DK
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1411-5. PubMed ID: 16750309
[TBL] [Abstract][Full Text] [Related]
36. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of cyclin E in low-risk node negative breast cancer.
Ahlin C; Gruhne B; Holmqvist M; Zetterberg A; Fjällskog ML
Acta Oncol; 2008; 47(8):1539-45. PubMed ID: 18607847
[TBL] [Abstract][Full Text] [Related]
38. Invasive lobular breast cancer: does grade matter?
Margenthaler JA
J Surg Res; 2011 Jul; 169(1):16-8. PubMed ID: 20850783
[No Abstract] [Full Text] [Related]
39. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer.
Yamashita H; Nishio M; Toyama T; Sugiura H; Zhang Z; Kobayashi S; Iwase H
Breast Cancer Res; 2004; 6(1):R24-30. PubMed ID: 14680497
[TBL] [Abstract][Full Text] [Related]
40. PPARgamma expression in breast cancer: clinical value and correlation with ERbeta.
Papadaki I; Mylona E; Giannopoulou I; Markaki S; Keramopoulos A; Nakopoulou L
Histopathology; 2005 Jan; 46(1):37-42. PubMed ID: 15656884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
